Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (114)	10/23/2000 2:19:47 PM
From: Nikole Wollerstein	Respond to of 278

"CNS may lead to ectopic axonal sprouting unrelated to and/or far in excess of that required for amelioration of the pathology-derived damage. In short, do the benefits really outweigh the risks? " theoretically it may but they already have multiple animal and human volunteer trial. I checked original papers year or so ago and experimental results look impressive But they do not have any knowledge about mechanism of AIT-082 action. That's a concern So I have only small position in NEOT